Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study

doi:10.12998/wjcc.v6.i10.373

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5606)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

336

WORD

182

HTML

2227

Figures (1-4)

263

Tables (1-4)

194

Sum=3202

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

847

Download

1557

Sum=2404

Sep 26, 2018 (publication date) through Jul 18, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 26, 2018; 6(10): 373-383
Published online Sep 26, 2018. doi: 10.12998/wjcc.v6.i10.373

Full Size Figure Download Figure

Figure 4 Kaplan-Meier curves for disease-free survival (A) and overall survival (B) between matched patients in the adjuvant S-1 plus oxaliplatin group and adjuvant capecitabine plus oxaliplatin group. SOX: S-1 plus oxaliplatin; XELOX: Capecitabine plus oxaliplatin; HR: Hazard ratio.

Citation: Ren DF, Zheng FC, Zhao JH, Shen GS, Ahmad R, Zhang SS, Zhang Y, Kan J, Dong L, Wang ZY, Zhao FX, Zhao JD. Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study. World J Clin Cases 2018; 6(10): 373-383
URL: https://www.wjgnet.com/2307-8960/full/v6/i10/373.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i10.373